{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:53:53Z","timestamp":1792691633997,"version":"4.5.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Human milk (HM) contributes to infant disease protection through transfer of numerous bioactive molecules, including antibodies, though the mechanisms that determine HM antibody transfer and disease prevention in the infant are not fully understood. Even less is known about the transfer of, and infant protection afforded by, vaccine-induced HM antibodies following vaccination during pregnancy or lactation. This systematic literature review aimed to summarize published evidence on the presence, duration and function of HM antibodies against pertussis, influenza and coronavirus disease 2019 (COVID-19) induced by vaccination during pregnancy or lactation and the associated protection against infant illness and to identify gaps to guide future research in this area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Literature searches were conducted on September 15, 2023, in MEDLINE and Embase for articles published since January 2000.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Eighteen studies reporting vaccine-induced antibodies in HM or protection against infant illness were included. The collective evidence supports increased and sustained HM antibody levels following influenza and COVID-19 vaccination while antipertussis HM antibody levels remained elevated for only approximately 4 weeks postvaccination. COVID-19 booster vaccination during pregnancy was found to prolong the half-life of immunoglobulin G antibodies in HM relative to the COVID-19 primary vaccination series. Only 2 studies evaluated illness among breastfed infants born to mothers vaccinated during pregnancy; however, neither distinguished the independent effects of transplacental transfer of vaccine-induced antibodies, HM transfer of vaccine-induced antibodies and HM transfer of naturally acquired antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>HM antibody levels are increased following pertussis, influenza and COVID-19 vaccination during pregnancy or lactation. However, the limited evidence base precludes conclusions about any incremental benefit of breastfeeding following vaccination during pregnancy versus the benefit of breastfeeding alone and studies designed to address this question are needed to inform vaccine policy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004634","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:02:29Z","timestamp":1739534549000},"page":"S38-S42","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Systematic Literature Review of Maternal Antibodies in Human Milk Following Vaccination During Pregnancy or Lactation: Tetanus, Pertussis, Influenza and COVID-19"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1535-1076","authenticated-orcid":false,"given":"Jennifer","family":"Deese","sequence":"first","affiliation":[{"name":"Global Scientific Affairs, Respiratory Vaccines and Anti-Infectives, Pfizer Inc., New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7822-3090","authenticated-orcid":false,"given":"Kassandra","family":"Schaible","sequence":"additional","affiliation":[{"name":"Evidera (part of Thermo Fisher Scientific), Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Massierer","sequence":"additional","affiliation":[{"name":"Evidera (part of Thermo Fisher Scientific), Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguhemen","family":"Tingir","sequence":"additional","affiliation":[{"name":"Vaccines Medical Development Doctor of Public Health Student Fellow, Global Scientific Affairs, Respiratory Vaccines and Anti-Infectives, Pfizer Inc., New York, New York"},{"name":"Morgan State University School of Community Health and Policy Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshayne B.","family":"Fell","sequence":"additional","affiliation":[{"name":"Global Scientific Affairs, Respiratory Vaccines and Anti-Infectives, Pfizer Inc., New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Atwell","sequence":"additional","affiliation":[{"name":"Global Scientific Affairs, Respiratory Vaccines and Anti-Infectives, Pfizer Inc., New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"R1-20260413","doi-asserted-by":"crossref","first-page":"e2022057989","DOI":"10.1542\/peds.2022-057989","article-title":"Policy statement: breastfeeding and the use of human milk.","volume":"150","author":"Meek","year":"2022","journal-title":"Pediatrics"},{"key":"R2-20260413","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/bfm.2013.0016","article-title":"Human milk glycoproteins protect infants against human pathogens.","volume":"8","author":"Liu","year":"2013","journal-title":"Breastfeed Med"},{"key":"R3-20260413","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"key":"R4-20260413","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/GRF.0b013e31824f3acb","article-title":"Vaccines in pregnant women and research initiatives.","volume":"55","author":"Healy","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"R5-20260413","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nrd.2015.38","article-title":"Making way for maternal immunization.","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"R6-20260413","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(03)13811-1","article-title":"How many child deaths can we prevent this year?","volume":"362","author":"Jones","year":"2003","journal-title":"Lancet"},{"key":"R7-20260413","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s42003-023-04910-2","article-title":"The cellular and immunological dynamics of early and transitional human milk.","volume":"6","author":"LeMaster","year":"2023","journal-title":"Commun Biol"},{"key":"R8-20260413","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/adc.62.4.401","article-title":"Local production of rotavirus specific IgA in breast tissue and transfer to neonates.","volume":"62","author":"Rahman","year":"1987","journal-title":"Arch Dis Child"},{"key":"R9-20260413","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0264-410X(98)00108-X","article-title":"Maternal immunization against viral disease.","volume":"16","author":"Englund","year":"1998","journal-title":"Vaccine"},{"key":"R10-20260413","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.vaccine.2014.01.083","article-title":"Breastfeeding after maternal immunisation during pregnancy: providing immunological protection to the newborn: a review.","volume":"32","author":"Maertens","year":"2014","journal-title":"Vaccine"},{"key":"R12-20260413","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R13-20260413","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1016\/j.vaccine.2018.06.036","article-title":"Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.","volume":"36","author":"Brady","year":"2018","journal-title":"Vaccine"},{"key":"R14-20260413","doi-asserted-by":"crossref","first-page":"e2323405","DOI":"10.1001\/jamanetworkopen.2023.23405","article-title":"Assessment of adverse reactions, antibody patterns, and 12-month outcomes in the mother-infant dyad after COVID-19 mRNA vaccination in pregnancy.","volume":"6","author":"Cassidy","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R15-20260413","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.2021.7563","article-title":"Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women.","volume":"325","author":"Collier","year":"2021","journal-title":"JAMA"},{"key":"R16-20260413","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41390-020-0966-7","article-title":"Active free secretory component and secretory IgA in human milk: do maternal vaccination, allergy, infection, mode of delivery, nutrition and active lifestyle change their concentrations?","volume":"89","author":"Demers-Mathieu","year":"2021","journal-title":"Pediatr Res"},{"key":"R17-20260413","first-page":"2022.11.29.518385","article-title":"SARS-CoV-2 vaccine booster elicits robust prolonged maternal antibody responses and passive transfer via the placenta and breastmilk.","author":"Marshall","year":"2022","journal-title":"bioRxiv"},{"key":"R18-20260413","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41385-022-00537-4","article-title":"Molecular alterations in human milk in simulated maternal nasal mucosal infection with live attenuated influenza vaccination.","volume":"15","author":"Pannaraj","year":"2022","journal-title":"Mucosal Immunol"},{"key":"R19-20260413","doi-asserted-by":"crossref","first-page":"e0287103","DOI":"10.1371\/journal.pone.0287103","article-title":"Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies.","volume":"18","author":"Rick","year":"2023","journal-title":"PLoS One"},{"key":"R20-20260413","doi-asserted-by":"crossref","first-page":"1154782","DOI":"10.3389\/fimmu.2023.1154782","article-title":"Assessment of human milk samples obtained pre and post-influenza vaccination reveals a poor boosting of seasonally-relevant, hemagglutinin-specific antibodies.","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"R21-20260413","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/cid\/cir538","article-title":"Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.","volume":"53","author":"Halperin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R22-20260413","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1016\/j.vaccine.2014.08.006","article-title":"The induction of breast milk pertussis specific antibodies following gestational tetanus-diphtheria-acellular pertussis vaccination.","volume":"32","author":"Abu Raya","year":"2014","journal-title":"Vaccine"},{"key":"R23-20260413","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajcnut.2023.07.013","article-title":"Maternal immunization during the second trimester with BNT162b2 mRNA vaccine induces a robust IgA response in human milk: a prospective cohort study.","volume":"118","author":"Kigel","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"R24-20260413","doi-asserted-by":"crossref","first-page":"e70867","DOI":"10.1371\/journal.pone.0070867","article-title":"IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization.","volume":"8","author":"Schlaudecker","year":"2013","journal-title":"PLoS One"},{"key":"R25-20260413","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00394-015-0845-x","article-title":"Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers only: a randomized clinical trial in Bangladesh.","volume":"55","author":"Siddiqua","year":"2016","journal-title":"Eur J Nutr"},{"key":"R26-20260413","doi-asserted-by":"crossref","first-page":"e1305","DOI":"10.1093\/cid\/ciab260","article-title":"Breast milk antibody levels in Tdap-vaccinated women after preterm delivery.","volume":"73","author":"Orije","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R27-20260413","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/cid\/ciac359","article-title":"Severe acute respiratory syndrome coronavirus 2 infection versus vaccination in pregnancy: implications for maternal and infant immunity.","volume":"75","author":"Conti","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R28-20260413","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijid.2023.02.022","article-title":"Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonate.","volume":"130","author":"Zilver","year":"2023","journal-title":"Int J Infect Dis"},{"key":"R29-20260413","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jped.2020.10.018","article-title":"Protective effect of exclusive breastfeeding and effectiveness of maternal vaccination in reducing pertussis-like illness.","volume":"97","author":"Nascimento","year":"2021","journal-title":"J Pediatr (Rio J)"},{"key":"R30-20260413","first-page":"80","article-title":"Antigenic stimulation during pregnancy modifies specific IgA1 and IgA2 subclasses in human colostrum according to the chemical composition of the antigen.","volume":"72","author":"Sanchez-Salguero","year":"2020","journal-title":"Rev Invest Clin"},{"key":"R31-20260413","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.3390\/ijms24032957","article-title":"Detection of SARS-CoV-2-specific antibodies in human breast milk and their neutralizing capacity after COVID-19 vaccination: a systematic review.","volume":"24","author":"Nicolaidou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R32-20260413","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3390\/nu15081905","article-title":"Anti-SARS-CoV-2 immunoglobulins in human milk after coronavirus disease or vaccination-time frame and duration of detection in human milk and factors that affect their titers: a systematic review.","volume":"15","author":"Dimitroglou","year":"2023","journal-title":"Nutrients"},{"key":"R33-20260413","doi-asserted-by":"crossref","first-page":"661806","DOI":"10.3389\/fimmu.2021.661806","article-title":"Breastfeeding and COVID-19: from nutrition to immunity.","volume":"12","author":"Vassilopoulou","year":"2021","journal-title":"Front Immunol"},{"key":"R34-20260413","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40121-019-00265-6","article-title":"Safety of maternal immunization against pertussis: a systematic review.","volume":"8","author":"D\u2019Heilly","year":"2019","journal-title":"Infect Dis Ther"},{"key":"R35-20260413","doi-asserted-by":"crossref","first-page":"e012376","DOI":"10.1136\/bmjgh-2023-012376","article-title":"Are maternal vaccines effective and safe for mothers and infants? A systematic review and meta-analysis of randomised controlled trials.","volume":"8","author":"de Bruin","year":"2023","journal-title":"BMJ Global Health"},{"key":"R36-20260413","doi-asserted-by":"crossref","first-page":"e009693","DOI":"10.1136\/bmjgh-2022-009693","article-title":"Impact of breastfeeding on the incidence and severity of respiratory syncytial virus (RSV)-associated acute lower respiratory infections in infants: a systematic review highlighting the global relevance of primary prevention.","volume":"8","author":"Mineva","year":"2023","journal-title":"BMJ Glob Health"},{"key":"R37-20260413","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/21645515.2017.1345385","article-title":"Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: a systematic review and meta-analysis.","volume":"14","author":"Nunes","year":"2018","journal-title":"Hum Vaccin Immunother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000004634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:12:15Z","timestamp":1785784335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000004634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"journal-issue":{"issue":"2S","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004634","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}